Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Lipopolysaccharide from Rhodobacter sphaeroides Attenuates Microglia-Mediated Inflammation and Phagocytosis and Directs Regulatory T Cell Response.
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Motor network efficiency and disability in multiple sclerosis.
Why does multiple sclerosis only affect human primates?
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
Neuroinflammation: Modulating mighty microglia.
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis.
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Caregiver burden in multiple sclerosis: A structured review of the instruments.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
Pages
« first
‹ previous
…
599
600
601
602
603
604
605
606
607
…
next ›
last »